Genome-wide association study across pediatric central nervous system tumors implicates shared predisposition and points to 1q25.2 (PAPPA2) and 11p12 (LRRC4C) as novel candidate susceptibility loci

[1]  L. S. Schmidt,et al.  A genome-wide association study on medulloblastoma , 2020, Journal of Neuro-Oncology.

[2]  J. Trent,et al.  Two novel genetic variants in the STK38L and RAB27A genes are associated with glioma susceptibility , 2019, International journal of cancer.

[3]  F. Jardin,et al.  A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC network study. , 2019, Neuro-oncology.

[4]  Q. Ostrom,et al.  Risk Factors For Childhood And Adult Primary Brain Tumors. , 2019, Neuro-oncology.

[5]  J. Biegel,et al.  Germline genetic landscape of pediatric central nervous system (CNS) tumors. , 2019, Neuro-oncology.

[6]  P. Wesseling,et al.  Molecular pathology of tumors of the central nervous system , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  C. Hultman,et al.  Genetic Variants in the 9p21.3 Locus Associated with Glioma Risk in Children, Adolescents, and Young Adults: A Case–Control Study , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[8]  I. Pollack,et al.  Childhood brain tumors: current management, biological insights, and future directions. , 2019, Journal of neurosurgery. Pediatrics.

[9]  Andreas Meyer-Lindenberg,et al.  Gimpute: an efficient genetic data imputation pipeline , 2018, Bioinform..

[10]  V. Hwa,et al.  PAPPA2 as a Therapeutic Modulator of IGF-I Bioavailability: in Vivo and in Vitro Evidence , 2018, Journal of the Endocrine Society.

[11]  M. Nöthen,et al.  Genome-wide association analysis identifies a meningioma risk locus at 11p15.5 , 2018, Neuro-oncology.

[12]  Michael C. Heinold,et al.  The landscape of genomic alterations across childhood cancers , 2018, Nature.

[13]  R. Houlston,et al.  Genome-Wide Association Studies in Glioma , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[14]  R. Houlston,et al.  Genome-wide association studies of cancer: current insights and future perspectives , 2017, Nature Reviews Cancer.

[15]  Gad Abraham,et al.  FlashPCA2: principal component analysis of biobank-scale genotype datasets , 2016, bioRxiv.

[16]  P. Visscher,et al.  10 Years of GWAS Discovery: Biology, Function, and Translation. , 2017, American journal of human genetics.

[17]  P. Northcott,et al.  Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  M. Daly,et al.  The iPSYCH2012 case–cohort sample: new directions for unravelling genetic and environmental architectures of severe mental disorders , 2017, Molecular Psychiatry.

[19]  D. Hougaard,et al.  Evaluation of whole genome amplified DNA to decrease material expenditure and increase quality , 2017, Molecular genetics and metabolism reports.

[20]  Ryan L. Collins,et al.  Implication of LRRC4C and DPP6 in neurodevelopmental disorders , 2017, American journal of medical genetics. Part A.

[21]  J. Zwart,et al.  The impact of body mass index and height on the risk for glioblastoma and other glioma subgroups: a large prospective cohort study , 2016, Neuro-oncology.

[22]  W. Chung,et al.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.

[23]  M. Nørgaard,et al.  Danish Childhood Cancer Registry , 2016, Clinical epidemiology.

[24]  Thomas Mailund,et al.  Nationwide Genomic Study in Denmark Reveals Remarkable Population Homogeneity , 2016, Genetics.

[25]  D. Tropea,et al.  The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity , 2016, Neuroscience.

[26]  L. Pérez-Jurado,et al.  Mutations in pregnancy‐associated plasma protein A2 cause short stature due to low IGF‐I availability , 2016, EMBO molecular medicine.

[27]  Li Ding,et al.  Germline Mutations in Predisposition Genes in Pediatric Cancer. , 2015, The New England journal of medicine.

[28]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[29]  Hong Chen,et al.  Common variants at 10p12.31, 10q21.1 and 13q12.13 are associated with sporadic pituitary adenoma , 2015, Nature Genetics.

[30]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[31]  Minghua Wu,et al.  Function and mechanism of tumor suppressor gene LRRC4/NGL-2 , 2014, Molecular Cancer.

[32]  Olivier Delaneau,et al.  Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel , 2014, Nature Communications.

[33]  J. Nielsen,et al.  Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics. , 2014, Molecular & cellular proteomics : MCP.

[34]  J. Nielsen,et al.  Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics* , 2013, Molecular & Cellular Proteomics.

[35]  Ron Edgar,et al.  LifeMap Discovery™: The Embryonic Development, Stem Cells, and Regenerative Medicine Research Portal , 2013, PloS one.

[36]  S. Weroha,et al.  The insulin-like growth factor system in cancer. , 2012, Endocrinology and metabolism clinics of North America.

[37]  M. Saif,et al.  IGF system in cancer: from bench to clinic , 2011, Anti-cancer drugs.

[38]  L. S. Schmidt,et al.  Incidence of childhood central nervous system tumors in the Nordic countries , 2011, Pediatric blood & cancer.

[39]  F. Wiklund,et al.  Systematic Reviews and Meta- and Pooled Analyses Familial Aggregation of Glioma: A Pooled Analysis , 2010 .

[40]  Josyf Mychaleckyj,et al.  Robust relationship inference in genome-wide association studies , 2010, Bioinform..

[41]  E. Monti,et al.  The IGFR1 inhibitor NVP-AEW541 disrupts a pro-survival and pro-angiogenic IGF-STAT3-HIF1 pathway in human glioblastoma cells. , 2010, Biochemical pharmacology.

[42]  Ayellet V. Segrè,et al.  Hundreds of variants clustered in genomic loci and biological pathways affect human height , 2010, Nature.

[43]  J. Olsen,et al.  Familial risks in nervous system tumours: joint Nordic study , 2010, British Journal of Cancer.

[44]  K. Thennarasu,et al.  Grade-Specific Expression of Insulin-like Growth Factor–Binding Proteins-2, -3, and -5 in Astrocytomas: IGFBP-3 Emerges as a Strong Predictor of Survival in Patients with Newly Diagnosed Glioblastoma , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[45]  L. S. Schmidt,et al.  Fetal Growth, Preterm Birth, Neonatal Stress and Risk for CNS Tumors in Children: A Nordic Population- and Register-Based Case-Control Study , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[46]  Melissa Bondy,et al.  Genome-wide association study identifies five susceptibility loci for glioma , 2009, Nature Genetics.

[47]  T. Ørntoft,et al.  Genome-wide scans using archived neonatal dried blood spot samples , 2009, BMC Genomics.

[48]  E. Milne,et al.  Involvement of the IGF system in fetal growth and childhood cancer: an overview of potential mechanisms , 2009, Cancer Causes & Control.

[49]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[50]  K. Hemminki,et al.  Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. , 2009, The Lancet. Oncology.

[51]  Paolo Vineis,et al.  Sequence variants at the TERT-CLPTM1L locus associate with many cancer types , 2009, Nature Genetics.

[52]  Christopher I Amos,et al.  Common 5p15.33 and 6p21.33 variants influence lung cancer risk , 2008, Nature Genetics.

[53]  M. D. Den Boer,et al.  Various components of the insulin‐like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients , 2008, International journal of cancer.

[54]  Sébastien Moretti,et al.  Bgee: Integrating and Comparing Heterogeneous Transcriptome Data Among Species , 2008, DILS.

[55]  M. Daly,et al.  Estimation of the multiple testing burden for genomewide association studies of nearly all common variants , 2008, Genetic epidemiology.

[56]  Xiaoling Li,et al.  LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses , 2008, Journal of cellular physiology.

[57]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[58]  D. Hougaard,et al.  Storage policies and use of the Danish Newborn Screening Biobank , 2007, Journal of Inherited Metabolic Disease.

[59]  Xiaoling Li,et al.  Expression and functional characterization of LRRC4, a novel brain‐specific member of the LRR superfamily , 2005, FEBS letters.

[60]  A. Gurney,et al.  The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical axons , 2003, Nature Neuroscience.

[61]  Gui-yuan Li,et al.  Expression of LRRC4 has the potential to decrease the growth rate and tumorigenesis of glioblastoma cell line U251. , 2003, Ai zheng = Aizheng = Chinese journal of cancer.

[62]  K. Lomthaisong,et al.  The characterization of pregnancy associated plasma protein-E and the identification of an alternative splice variant. , 2001, Placenta.

[63]  C. Conover,et al.  Pregnancy-associated Plasma Protein-A2 (PAPP-A2), a Novel Insulin-like Growth Factor-binding Protein-5 Proteinase* , 2001, The Journal of Biological Chemistry.

[64]  D. Dunger,et al.  Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. , 2000, The Journal of clinical endocrinology and metabolism.

[65]  S. Vandenberg,et al.  Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas. , 1999, Neuro-oncology.

[66]  A. Dekaban,et al.  Changes in brain weights during the span of human life: Relation of brain weights to body heights and body weights , 1978, Annals of neurology.

[67]  Jill S Barnholtz-Sloan,et al.  Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011. , 2015, Neuro-oncology.

[68]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[69]  S. Weroha,et al.  IGF System in Cancer IGF System and Cancer Risk , 2013 .

[70]  R. Barnard,et al.  The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.